Context Therapeutics (NASDAQ: CNTX)

Last close As at 01/11/2024

1.22

0.00 (0.00%)

Market capitalisation

USD19m

Latest Insights

View More
Doctor with cancer patient

Balance Sheet

Forecast net debt (US$m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 119.1 79.4 (38.7)
Relative 106.7 60.8 (47.6)
52 week high/low US$2.3/US$0.5

Financials

Edison Investment Research is terminating coverage on Context Therapeutics (CNTX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (US$m) EBITDA (US$m) PBT (US$m) EPS (fd) (c) P/E (x) P/CF (x)
2021A 0.0 (10.5) (10.6) (373.72) N/A N/A
2022A 0.0 (15.4) (14.8) (93.00) N/A N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Further insights

insight

Healthcare

Healthcare Week 2023

insight

Healthcare

Forging better lives: Seeking radical change for cancers

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free